Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LHM Oral Solution for MRCP Imaging
CTR20180366Phase 2Completed
- Sponsor
- Nanjing Zhulu Pharmaceutical Technology Co., Ltd.
- Start
- Jun 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyoscyamine in None, sponsored by Nanjing Zhulu Pharmaceutical Technology Co., Ltd.. Started Jun 2018; status: completed.
02
Drugs
hyoscyamine
Beyond the preview
Go deeper on CTR20180366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180366.